MENUNews Archive
Date: 02/21/2018
When PGE2 is out of balance and the body makes too much, it can lead to inflammation and to conditions such as cancer and heart disease. Other fatty acids, particularly omega-3 fatty acids, reduce the amount of omega-6 fatty acids available in a cell. This is a key system that controls how much PGE2 the cell makes
Date: 02/15/2018
Every kind of cancer can spread to the spine, yet two physician-scientists who treat these patients describe a lack of guidance for effectively providing care and minimizing pain.
Date: 02/06/2018
In an article in U.S. News and World Report, Reshma Jagsi, M.D., D.Phil., describes recent advances in radiation therapy to treat breast cancer.
Date: 02/01/2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. U-M Rogel Cancer Center researchers studied mice with colon cancer, ovarian cancer, melanoma and lung cancer to understand how expression of the protein PD-L1 affects response to its blockade. This is a key target of immunotherapy drugs.
Date: 01/31/2018
Cancerous cells are known activate an enzyme called telomerase, causing the cells to divide ceaselessly, a hallmark of cancer. Now, University of Michigan researchers have identified a region on a protein called TPP1 that binds this enzyme, which could provide a target for anticancer drugs.
Date: 01/31/2018
Researchers found that 1 in 7 patients undergoing lung cancer surgery became new persistent opioid users after surgery, establishing opioid dependence as a postoperative complication that is as common as others, including atrial fibrillation.
Date: 01/30/2018
The Wall Street Journal looks at efforts to improve how oncologists determine which patients need chemotherapy. What once was a crucial part of cancer treatment might now be best avoided for some patients at low risk. The article cites research from U-M Rogel Cancer Center member Steven Katz, M.D., MPH.
Date: 12/27/2017
Researchers at the University of Michigan Rogel Cancer Center uncovered a novel gene they named THOR while investigating previously unexplored regions of the human genome -- or the human genome’s dark matter.
Date: 12/13/2017
After defining the scope of sexual harassment in medicine, a physician says sharing stories and a national reckoning offer hope for progress.
Date: 12/08/2017
Most cancer immunotherapy research has targeted effector T cells, but a new study steps back and considers: What if the problem isn’t with the effector T cells, but starts higher up the cellular chain? And so researchers looked at naive T cells -- a type of immune cell that hasn’t yet been triggered to fight.